Consumer Retailing Healthcare Sector

Absci

Market Cap: US$338.0m

Operates as a data-first generative artificial intelligence (AI) drug creation company in the United States.

ClearPoint Neuro

Market Cap: US$333.8m

Operates as a medical device company primarily in the United States.

SNDL

Market Cap: US$326.8m

Engages in the production, distribution, and sale of cannabis products for the adult-use market in Canada.

Nano-X Imaging

Market Cap: US$326.8m

Develops a commercial-grade tomographic imaging device with a digital X-ray source.

Varex Imaging

Market Cap: US$318.4m

Designs, manufactures, and sells X-ray imaging components.

Outset Medical

Market Cap: US$311.4m

A medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States.

Alpha Teknova

Market Cap: US$308.4m

Produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.

Quantum-Si

Market Cap: US$308.3m

A life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS).

National Research

Market Cap: US$307.8m

Provides analytics and insights that facilitate measurement and improvement of the patient and employee experience.

EBR Systems

Market Cap: AU$476.3m

Develops implantable systems for wireless tissue stimulation.

ADC Therapeutics

Market Cap: US$306.5m

Provides antibody drug conjugate (ADC) technology platform to transform the treatment paradigm for patients with hematologic malignancies and solid tumors.

Abeona Therapeutics

Market Cap: US$302.9m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

Rapport Therapeutics

Market Cap: US$301.8m

Operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders.

Cryoport

Market Cap: US$301.3m

Provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide.

XOMA Royalty

Market Cap: US$296.3m

Operates as a biotech royalty aggregator in the United States and the Asia Pacific.

Phathom Pharmaceuticals

Market Cap: US$296.0m

A biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases.

Corvus Pharmaceuticals

Market Cap: US$291.5m

A clinical stage biopharmaceutical company, engages in the development of product candidates that precisely target proteins that are critical to immune cell maturation and function in the United States.

Aurora Cannabis

Market Cap: CA$399.0m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

Compass Therapeutics

Market Cap: US$290.4m

A clinical-stage oncology-focused biopharmaceutical company, engages in the development of antibody-based therapeutics for the treatment of various human diseases in the United States.

Pacific Biosciences of California

Market Cap: US$289.2m

Designs, develops, and manufactures sequencing solution to resolve genetically complex problems.

Heron Therapeutics

Market Cap: US$286.8m

A commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care.

Oncology Institute

Market Cap: US$284.7m

An oncology company, provides various medical oncology services in the United States.

Cidara Therapeutics

Market Cap: US$281.2m

Operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases.

Silence Therapeutics

Market Cap: US$275.8m

A biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.

Candel Therapeutics

Market Cap: US$273.1m

A clinical stage biopharmaceutical company, develops immunotherapies for the cancer patients.

Oceania Healthcare

Market Cap: NZ$456.3m

Owns and operates retirement villages and care centres in New Zealand.

Cresco Labs

Market Cap: CA$373.2m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States.

NervGen Pharma

Market Cap: CA$373.1m

A biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease.

Terns Pharmaceuticals

Market Cap: US$271.6m

A clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity.

Rocket Pharmaceuticals

Market Cap: US$270.4m

Operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases in the United States.

Aquestive Therapeutics

Market Cap: US$269.2m

Operates as a pharmaceutical company in the United States and internationally.

Immutep

Market Cap: AU$416.2m

A late-stage biotechnology company, engages in developing novel LAG-3 related immunotherapies for cancer and autoimmune diseases in Australia.

Astria Therapeutics

Market Cap: US$268.6m

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States.

Entrada Therapeutics

Market Cap: US$268.0m

A clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases.

Palvella Therapeutics

Market Cap: US$266.8m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases.

Tvardi Therapeutics

Market Cap: US$265.3m

Operates as a biotechnology company, engages in the development of novel, oral, and small molecule therapies targeting STAT3 to treat fibrosis-driven diseases.